PMID- 31067319 OWN - NLM STAT- MEDLINE DCOM- 20191010 LR - 20191010 IS - 1552-5783 (Electronic) IS - 0146-0404 (Linking) VI - 60 IP - 6 DP - 2019 May 1 TI - Vitreomacular Interface Abnormalities and Glaucoma in an Elderly Population (The MONTRACHET Study). PG - 1996-2002 LID - 10.1167/iovs.18-26510 [doi] AB - PURPOSE: To investigate the prevalence of vitreomacular interface abnormalities (VMIAs) in a French elderly glaucomatous population. METHODS: Using a population-based study, the MONTRACHET (Maculopathy Optic Nerve nuTRition neurovAsCular and HEarT diseases) study conducted in Dijon from 2009 to 2013 in individuals older than 75 years, the prevalence of VMIAs was estimated on glaucoma patients. RESULTS: A total of 1130 participants (2225 eyes) were included in the study. The mean age of participants was 82.3 +/- 3.8 years, and 62.74% were women. Regarding the frequency of all VMIAs, there was no statistical difference between glaucoma patients and nonglaucoma participants (51.85% vs. 53.92%, respectively, P = 0.372). In univariate analysis, vitreomacular adherences were more frequent in nonglaucoma participants (18.39% vs. 10.78%, P = 0.036). Epiretinal membranes were more frequent in the glaucomatous population (47.06% vs. 38.13%, P = 0.018). The prevalence of macular cysts was comparable in the two groups (7.84% vs. 5.64%, P = 0.262). Macular cysts were more frequent in eyes treated with preservative-free, IOP-lowering eye drops when compared with the eyes of nonglaucomatous participants treated with IOP-lowering eye drops containing a preservative (26.67% vs. 3.37% and 5.76%, respectively, P < 0.001). In multivariate analysis, these results were no longer significant. CONCLUSIONS: The prevalence of VMIAs was high in this elderly population and similar in both glaucomatous and nonglaucomatous participants. The information provided by macular optical coherence tomography scans should be considered with caution when used for glaucoma management in elderly patients. FAU - Blanc, Julie AU - Blanc J AD - University Hospital, Department of Ophthalmology, Dijon, France. FAU - Seydou, Alassane AU - Seydou A AD - Institut National de la Sante et de la Recherche Medicale (INSERM), Clinical Center Investigation, Clinical Epidemiology/Clinical Trials Unit, Universal Hospital, Dijon, France. AD - Centre des Sciences du Gout et de l'Alimentation, Centre National pour la Recherche Scientifique (CNRS), Institut National de la Recherche Agronomique (INRA), University Bourgogne Franche-Comte, Dijon, France. FAU - Ben Ghezala, Ines AU - Ben Ghezala I AD - University Hospital, Department of Ophthalmology, Dijon, France. FAU - Deschasse, Clemence AU - Deschasse C AD - University Hospital, Department of Ophthalmology, Dijon, France. FAU - Meillon, Cyril AU - Meillon C AD - University Hospital, Department of Ophthalmology, Dijon, France. FAU - Bron, Alain M AU - Bron AM AD - University Hospital, Department of Ophthalmology, Dijon, France. AD - Centre des Sciences du Gout et de l'Alimentation, Centre National pour la Recherche Scientifique (CNRS), Institut National de la Recherche Agronomique (INRA), University Bourgogne Franche-Comte, Dijon, France. FAU - Binquet, Christine AU - Binquet C AD - Institut National de la Sante et de la Recherche Medicale (INSERM), Clinical Center Investigation, Clinical Epidemiology/Clinical Trials Unit, Universal Hospital, Dijon, France. AD - Centre des Sciences du Gout et de l'Alimentation, Centre National pour la Recherche Scientifique (CNRS), Institut National de la Recherche Agronomique (INRA), University Bourgogne Franche-Comte, Dijon, France. FAU - Creuzot-Garcher, Catherine AU - Creuzot-Garcher C AD - University Hospital, Department of Ophthalmology, Dijon, France. AD - Centre des Sciences du Gout et de l'Alimentation, Centre National pour la Recherche Scientifique (CNRS), Institut National de la Recherche Agronomique (INRA), University Bourgogne Franche-Comte, Dijon, France. LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 SB - IM MH - Aged MH - Aged, 80 and over MH - Comorbidity MH - Female MH - Follow-Up Studies MH - France/epidemiology MH - Glaucoma/*diagnosis/epidemiology/physiopathology MH - Humans MH - Intraocular Pressure/*physiology MH - Male MH - Nerve Fibers/pathology MH - Prospective Studies MH - Retinal Diseases/*diagnosis/epidemiology/physiopathology MH - Retinal Ganglion Cells/*pathology MH - Tomography, Optical Coherence/*methods MH - *Visual Acuity EDAT- 2019/05/09 06:00 MHDA- 2019/10/11 06:00 CRDT- 2019/05/09 06:00 PHST- 2019/05/09 06:00 [entrez] PHST- 2019/05/09 06:00 [pubmed] PHST- 2019/10/11 06:00 [medline] AID - 2733391 [pii] AID - 10.1167/iovs.18-26510 [doi] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2019 May 1;60(6):1996-2002. doi: 10.1167/iovs.18-26510.